Rapid susceptibility testing of fungi by flow cytometry using vital staining

Journal of Clinical Microbiology

Volumn 35, Issue 1, 1997, Pages 5-10

  Wenisch, Christoph ^a,b   Linnau, Ken Floris ^a   Parschalk, Bernhard ^a   Zedtwitz Liebenstein, Konstantin ^a   Georgopoulos, Apostolos ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; KETOCONAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA ALBICANS; FLOW CYTOMETRY; FUNGUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; VITAL STAIN;

CANDIDA ALBICANS; FUNGI;

EID: 0031059982     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.1.5-10.1997     Document Type: Article

References (27)

1. Anaissie, E. J., G. P. Bodey, and M. G. Rinaldi. 1989. Emerging fungal pathogens. Eur. J. Clin. Microbiol. Infect. Dis. 8:323-330.
2. Banerjee, S. N., T. G. Emori, D. H. Culver, R. P. Gaynes, W. R. Jarvis, T. Horan, J. R. Edward, J. Tolson, T. Henderson, W. J. Maroane, and the National Nosocomial Infections Surveillance System. 1991. Secular trends in nosocomial primary bloodstream infections in the United States. 1980-1989. Am. J. Med. 91:86-89.
3. Barchiesi, F., A. L. Colombo, D. A. McGough, A. W. Fothergill, and M. G. Rinaldi. 1994. In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities from patients infected with the human immunodeficiency virus. Antimicrob. Agents Chemother. 38:1530-1533.
4. Burgess, S. M., M. Delannoy, and R. E. Jensen. 1994 MMM1 encodes a mitochondrial outer membrane protein essential or establishing and maintaining the structure of yeast mitochondria. J. Cell Biol. 126:1375-1391.
5. Calhoun, D. L., G. D. Roberts, J. N. Galgiani, J. E. Bennet, D. S. Feingold, J. Jorgenson, G. S. Kobayashi, and S. Shadomy. 1986. Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B. J. Clin. Microbiol. 23:298-301.
6. Espinel-Ingroff, A., J. L. Rodríguez-Tudela, and J. V. Martínez-Suárez. 1995. Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans. J. Clin. Microbiol. 33:3154-3158.
7. Galgiani, J. N. 1987. Antifungal susceptibility tests: current status of the standardization process. Antimicrob. Agents Chemother. 31:1867-1870.
8. Garter, E. A., F. E. Paul, and P. A. Hunter. 1993. Cytometric evaluation of antifungal agents, p. 111-120. In D. Lloyd (ed.). Flow cytometry in microbiology. Springer, New York.
9. Ghannoum, M. A., J. H. Rex, and J. N. Galgiani. 1996. Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome. J. Clin. Microbiol. 34:489-495.
10. Green, L., B. Petersen, L. Steimel, P. Haeber, and W. Current. 1994. Rapid determination of antifungal activity by flow cytometry. J. Clin. Microbiol. 32:1088-1091.
11. Hector, R. F., P. C. Braun, T. J. Hart, and M. E. Kamarck. 1990. The use of flow cytometry to monitor chitin synthesis in regenerating protoplasts of Candida albicans. J. Med. Vet. Mycol. 28:51-57.
12. Hitchcock, C. A., G. W. Pye, P. F. Troke, E. M. Johnson, and D. W. Warnock. 1993. Fluconazole resistance in Candida glabrata. Antimicrob. Agents Chemother. 37:1962-1965.
13. Horsburgh, C. R., and C. H. Kirkpatrick. 1983. Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients. Am. J. Med. 74:23-29.
14. Kerkering, T. M. 1987. Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods. Antimicroh. Agents Chemother. 31:1343-1347.
15. Mason, D. J., and V. A. Gant. 1995. The application of flow cytometry of the estimation of bacterial antibiotic susceptibility. J. Antimicrob. Chemother. 36:441-443.
16. Merz, W. G. 1984. Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance. J. Clin. Microbiol. 20:1194-1195.
17. National Committee for Clinical Laboratory Standards. 1992. Reference method for broth dilution antifungal susceptibility testing for yeasts. Proposed standard M27-P. National Committee for Clinical Laboratory. Standards, Villanova, Pa.
18. O'Gorman, M. R., and R. L. Hopfer. 1991. Amphotericin B susceptibility testing of Candida species by flow cytometry. Cytometry 12:743-747.
19. Ordonez, J. V., and N. M. Wehmann. 1995. Amphotericin B susceptibility of Candida species assessed by rapid flow cytometric membrane potential assay. Cytometry 22:154-157.
20. Pfaller, M. A., M. Bale, B. Buschelmann, M. Lancaster, A. Espinel-Ingroff, J. H. Rex, M. G. Rinaldi, C. R. Cooper, and M. R. McGinnis. 1995. Quality control guidelines for National Committee for National Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine. J. Clin. Microbiol. 33:1104-1107.
21. Pore, R. S. 1994. Antibiotic susceptibility testing by flow cytometry. J. Antimicrob. Chemother. 34:613-627.
22. Pore, R. S. 1990. Antibiotic susceptibility testing of Candida albicans by flow cytometry. Curr. Microbiol. 20:323-328.
23. Pore, R. S. 1991. Ketoconazole susceptibility of yeast by the FCST method. Curr. Microbiol. 23:45-50.
24. Reinders, P. P., P. H. van Vianen, M. van der Keur, A. van Engen, C. J. Janse, and H. J. Tanke. 1995. Computer software for testing drug susceptibility of malaria parasites. Cytometry 19:273-281.
25. Rex, J. H., M. A. Pfaller, M. G. Rinaldi, A. Polak, and J. N. Galgiani. 1993. Antifungal susceptibility testing. Clin. Microbiol. Rev. 6:367-381.
26. Stiller, R. L., J. E. Bennett, H. J. Scholer, M. Wall, A. Polak, and D. A. Stevens. 1982. Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States. Antimicrob. Agents Chemother. 22:482-487.
27. Wingard, J. R., W. G. Merz, M. G. Rinaldi, T. R. Johnson, J. E. Karp, and R. Saral. 1991. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N. Engl. J. Med. 325:1274-1277.